Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.85	1.53	7.79
Cash & Short-Term Investments	0.85	1.53	7.79
Cash Growth	-44.31%	-80.39%	-
Accounts Receivable	0.84	0.83	1.62
Other Receivables	0.25	-	-
Receivables	1.09	0.83	1.62
Inventory	22	22.43	17.12
Prepaid Expenses	0.76	0.94	-
Other Current Assets	0.9	0.63	0.89
Total Current Assets	25.59	26.35	27.42
Property, Plant & Equipment	19.35	16.22	12.55
Other Intangible Assets	0.47	0.26	0.06
Total Assets	45.42	42.84	40.03
Accounts Payable	10.54	9.95	8.14
Accrued Expenses	0.24	0.35	0.04
Current Portion of Long-Term Debt	0.93	-	0.75
Current Portion of Leases	2.16	2.01	1.17
Current Income Taxes Payable	0.4	0.41	0.37
Current Unearned Revenue	0.03	0.04	0.06
Total Current Liabilities	14.29	12.76	10.52
Long-Term Debt	1.78	-	-
Long-Term Leases	5.83	5.61	4.67
Total Liabilities	23.05	19.24	15.83
Common Stock	15.2	15.2	15.2
Additional Paid-In Capital	6.7	6.18	6.85
Retained Earnings	0.59	2.31	2.19
Comprehensive Income & Other	-0.11	-0.1	-0.04
Shareholders' Equity	22.37	23.59	24.2
Total Liabilities & Equity	45.42	42.84	40.03
Total Debt	10.69	7.62	6.58
Net Cash (Debt)	-9.84	-6.09	1.21
Net Cash Per Share	-6.47	-4.01	0.79
Filing Date Shares Outstanding	1.52	1.52	1.52
Total Common Shares Outstanding	1.52	1.52	1.52
Working Capital	11.3	13.6	16.9
Book Value Per Share	14.72	15.52	15.92
Tangible Book Value	21.9	23.33	24.14
Tangible Book Value Per Share	14.40	15.35	15.88
Land	2.5	-	-
Buildings	6.91	6.07	5.46
Machinery	6.93	6.56	4.24
Construction In Progress	1.07	0.05	0.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.